WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.
WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.
